Amrutanjan and Jagsonpal Offer Contrasting Cash-Return Investment Cases

Amrutanjan Health Care and Jagsonpal Pharmaceuticals are two Indian drug companies being considered for an investment watchlist.

Both earn strong returns from the money used in their businesses and have very little debt.

Amrutanjan is building a large factory to make sanitary napkins itself.

However, its main pain-relief business has barely grown, and recent profits dropped sharply.

Jagsonpal has improved its profit margins and has a large amount of cash.

It also bought most of a company called Aequitas Healthcare to gain access to hospitals.

Aequitas is currently only slightly profitable, so the purchase still needs to succeed.

Both companies pay dividends, but Jagsonpal’s recent yield includes a special payment.

The article says investors should watch both companies rather than treat the analysis as a recommendation.